• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的宿主-微生物群相互作用。

Host-microbiota interactions in inflammatory bowel disease.

机构信息

Department of Pathology and Rogel Cancer Center, the University of Michigan Medical School, Ann Arbor, Michigan, USA.

出版信息

Nat Rev Immunol. 2020 Jul;20(7):411-426. doi: 10.1038/s41577-019-0268-7. Epub 2020 Jan 31.

DOI:10.1038/s41577-019-0268-7
PMID:32005980
Abstract

The mammalian intestine is colonized by trillions of microorganisms that have co-evolved with the host in a symbiotic relationship. The presence of large numbers of symbionts near the epithelial surface of the intestine poses an enormous challenge to the host because it must avoid the activation of harmful inflammatory responses to the microorganisms while preserving its ability to mount robust immune responses to invading pathogens. In patients with inflammatory bowel disease, there is a breakdown of the multiple strategies that the immune system has evolved to promote the separation between symbiotic microorganisms and the intestinal epithelium and the effective killing of penetrant microorganisms, while suppressing the activation of inappropriate T cell responses to resident microorganisms. Understanding the complex interactions between intestinal microorganisms and the host may provide crucial insight into the pathogenesis of inflammatory bowel disease as well as new avenues to prevent and treat the disease.

摘要

哺乳动物的肠道定植着数以万亿计的微生物,这些微生物与宿主在共生关系中共同进化。大量共生体存在于肠道的上皮表面附近,这对宿主构成了巨大的挑战,因为它必须避免对微生物激活有害的炎症反应,同时保持其对入侵病原体产生强大免疫反应的能力。在炎症性肠病患者中,免疫系统进化出的多种策略会失效,这些策略旨在促进共生微生物与肠道上皮的分离,以及有效杀灭穿透性微生物,同时抑制对常驻微生物的不适当 T 细胞反应的激活。了解肠道微生物和宿主之间的复杂相互作用可能为炎症性肠病的发病机制提供重要的见解,并为预防和治疗这种疾病开辟新的途径。

相似文献

1
Host-microbiota interactions in inflammatory bowel disease.炎症性肠病中的宿主-微生物群相互作用。
Nat Rev Immunol. 2020 Jul;20(7):411-426. doi: 10.1038/s41577-019-0268-7. Epub 2020 Jan 31.
2
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.肠道微生物群:在病原体定植、免疫反应和炎症性疾病中的作用。
Immunol Rev. 2017 Sep;279(1):70-89. doi: 10.1111/imr.12567.
3
Microbiota-antibody interactions that regulate gut homeostasis.微生物群-抗体相互作用调节肠道内稳态。
Cell Host Microbe. 2021 Mar 10;29(3):334-346. doi: 10.1016/j.chom.2021.02.009.
4
[Intestinal immune response is regulated by gut microbe].肠道免疫反应受肠道微生物调节。
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):408-415. doi: 10.2177/jsci.40.408.
5
The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system.聚糖在健康和疾病中的作用:调节肠道微生物群和宿主免疫系统之间的相互作用。
Semin Immunol. 2024 May;73:101891. doi: 10.1016/j.smim.2024.101891. Epub 2024 Oct 10.
6
T-cell selection and intestinal homeostasis.T细胞选择与肠道内稳态。
Immunol Rev. 2014 May;259(1):60-74. doi: 10.1111/imr.12171.
7
Control of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiota.通过自然杀伤T细胞与肠道微生物群之间的相互作用来控制肠道稳态。
Clin Immunol. 2015 Aug;159(2):128-33. doi: 10.1016/j.clim.2015.05.008. Epub 2015 May 16.
8
The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.共生微生物菌群在体内平衡和胃肠道疾病中的多方面作用。
J Immunol Res. 2015;2015:321241. doi: 10.1155/2015/321241. Epub 2015 Feb 22.
9
Gut microbiota and systemic immunity in health and disease.肠道微生物群与健康和疾病中的全身免疫。
Int Immunol. 2021 Mar 31;33(4):197-209. doi: 10.1093/intimm/dxaa079.
10
Type 3 regulatory T cells at the interface of symbiosis.共生界面的 3 型调节性 T 细胞。
J Microbiol. 2018 Mar;56(3):163-171. doi: 10.1007/s12275-018-7565-x. Epub 2018 Feb 28.

引用本文的文献

1
Review: microbial metabolites - a key to address gut inflammation and barrier dysfunction in the premature infant.综述:微生物代谢产物——解决早产儿肠道炎症和屏障功能障碍的关键
Gut Microbes. 2025 Dec;17(1):2551117. doi: 10.1080/19490976.2025.2551117. Epub 2025 Aug 31.
2
Effects of oral gavage with periodontal pathogens and plaque biofilm on gut microbiota ecology and intestinal tissue architecture in mice: a mechanistic study.经口灌胃牙周病原体和菌斑生物膜对小鼠肠道微生物群生态和肠道组织结构的影响:一项机制研究
Front Cell Infect Microbiol. 2025 Aug 8;15:1589055. doi: 10.3389/fcimb.2025.1589055. eCollection 2025.
3

本文引用的文献

1
induces intestinal adaptive immune responses during homeostasis.在体内平衡期间,诱导肠道适应性免疫反应。
Science. 2019 Jun 21;364(6446):1179-1184. doi: 10.1126/science.aaw7479.
2
A specific gene-microbe interaction drives the development of Crohn's disease-like colitis in mice.特定的基因-微生物相互作用导致小鼠出现类似克罗恩病的结肠炎。
Sci Immunol. 2019 Apr 19;4(34). doi: 10.1126/sciimmunol.aaw4341.
3
Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease.粪便微生物群移植在炎症性肠病治疗中的作用洞察。
Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential.
后生元作为炎症性肠病中线粒体调节剂:机制洞察与治疗潜力
Biomolecules. 2025 Jul 1;15(7):954. doi: 10.3390/biom15070954.
4
Metagenomic polymorphic toxin effector and immunity profiling predicts microbiome development and disease-related dysbiosis.宏基因组多态性毒素效应物和免疫谱分析可预测微生物组发育及疾病相关的生态失调。
bioRxiv. 2025 Jul 8:2025.07.08.662037. doi: 10.1101/2025.07.08.662037.
5
Identification of medication-microbiome interactions that affect gut infection.鉴定影响肠道感染的药物-微生物组相互作用。
Nature. 2025 Jul 16. doi: 10.1038/s41586-025-09273-8.
6
New potential biomarkers of ulcerative colitis and disease course - integrated metagenomic and metabolomic analysis among Polish patients.溃疡性结肠炎及疾病进程的新潜在生物标志物——波兰患者的宏基因组与代谢组学综合分析
J Gastroenterol. 2025 Jul 4. doi: 10.1007/s00535-025-02280-6.
7
VBayesMM: variational Bayesian neural network to prioritize important relationships of high-dimensional microbiome multiomics data.VBayesMM:用于对高维微生物组多组学数据的重要关系进行优先级排序的变分贝叶斯神经网络。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf300.
8
Emerging gut microbial glycoside hydrolase inhibitors.新兴的肠道微生物糖苷水解酶抑制剂
RSC Chem Biol. 2025 Jun 11. doi: 10.1039/d5cb00050e.
9
Yeast microcapsules encapsulating metal-phenolic nanozymes alleviate ulcerative colitis by mitigating oxidative stress and modulating the gut microbiota.包裹金属酚类纳米酶的酵母微胶囊通过减轻氧化应激和调节肠道微生物群来缓解溃疡性结肠炎。
Mater Today Bio. 2025 May 23;32:101902. doi: 10.1016/j.mtbio.2025.101902. eCollection 2025 Jun.
10
Working together: gut microbe-microbe interactions shape host inflammation.协同作用:肠道微生物间的相互作用影响宿主炎症反应。
Infect Immun. 2025 Jul 8;93(7):e0051224. doi: 10.1128/iai.00512-24. Epub 2025 Jun 13.
Therap Adv Gastroenterol. 2019 Mar 14;12:1756284819836893. doi: 10.1177/1756284819836893. eCollection 2019.
4
Epithelial endoplasmic reticulum stress orchestrates a protective IgA response.上皮内质网应激调控保护性 IgA 应答。
Science. 2019 Mar 1;363(6430):993-998. doi: 10.1126/science.aat7186.
5
Microbial network disturbances in relapsing refractory Crohn's disease.复发缓解型和难治性克罗恩病中的微生物网络紊乱
Nat Med. 2019 Feb;25(2):323-336. doi: 10.1038/s41591-018-0308-z. Epub 2019 Jan 21.
6
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt Regulatory T Cells and Exacerbate Colitis in Mice.炎症性肠病患者的微生物群改变了肠道 Th17 和 RORγt 调节性 T 细胞的平衡,并在小鼠中加重结肠炎。
Immunity. 2019 Jan 15;50(1):212-224.e4. doi: 10.1016/j.immuni.2018.12.015.
7
Gut microbiome structure and metabolic activity in inflammatory bowel disease.炎症性肠病中的肠道微生物组结构和代谢活性。
Nat Microbiol. 2019 Feb;4(2):293-305. doi: 10.1038/s41564-018-0306-4. Epub 2018 Dec 10.
8
IgA Responses to Microbiota.IgA 对微生物组的反应。
Immunity. 2018 Aug 21;49(2):211-224. doi: 10.1016/j.immuni.2018.08.011.
9
T Cell Proliferation and Colitis Are Initiated by Defined Intestinal Microbes.T 细胞增殖和结肠炎由特定的肠道微生物引发。
J Immunol. 2018 Jul 1;201(1):243-250. doi: 10.4049/jimmunol.1800236. Epub 2018 May 18.
10
Gut microbiota utilize immunoglobulin A for mucosal colonization.肠道微生物群利用免疫球蛋白 A 进行黏膜定植。
Science. 2018 May 18;360(6390):795-800. doi: 10.1126/science.aaq0926. Epub 2018 May 3.